- CEO
- Jun Chen
- Full Time Employees
- 3,884
- Sector
- Consumer non-durables
- Industry
- Apparel/Footwear
- Address
- Chengxi Park Tangshan HE China 063500
- IPO Date
- Apr 27, 2021
- Business
- Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ) researches, develops, manufactures, and sells disposable medical consumables and equipment, focusing on health protection products, safe infusion systems, and innovation incubation solutions; its core offerings include nitrile gloves, PVC gloves, natural latex gloves, neoprene gloves, deproteinized gloves, medical radiation-proof gloves, anti-nuclear radiation gloves, wet gloves, double-layer two-color gloves, disposable exam gloves, surgical gloves, protective gloves, condoms, syringes, infusion sets, blood collection needles, indwelling needles, precision filter infusion sets, sterile dispensing syringes, vacuum blood-collecting vessels, portable electronic analgesic pumps, enteral nutrition pumps, infusion pumps, non-invasive temperature monitoring systems, disposable EEG electrodes, medical temperature sensors, blood pressure cuffs, and radial artery compression tourniquets. Founded in 2010 and headquartered in Tangshan, Hebei Province, China, the company operates five production bases across Tangshan (Hebei), Jiujiang and Yichun (Jiangxi), Guangyuan (Sichuan), Guilin (Guangxi), and Shenzhen (Guangdong), with subsidiaries in Beijing, Hong Kong, the United States, and the Netherlands; it maintains an annual production capacity exceeding 10 billion gloves and holds 225 patents as a national high-tech enterprise under Zhonghong Pulin Group, a core member of Fortune 500-listed Xiamen ITG Holding Group. Geographically, it serves medical, industrial, food, and healthcare sectors in China and international markets, ranking among China's top 500 listed medical device manufacturers. Recent developments include plans in 2024-2025 to invest 557 million yuan in the first phase of the SEA2 nitrile glove production base with 10 lines and the SEA1 project with 20 lines after terminating a prior medical-grade glove initiative in Sichuan for global strategy alignment; subsidiary products like enteral nutrition pumps, nasal cannulas, and injectors received registration certificates, renewals, and selections for regional bulk procurement; and in 2023, it completed the 58.8 million yuan acquisition of 70% stake in Shenzhen MedRena Biotech Co., Ltd.